Egyptian Rheumatologist
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.8 | Q4 | 10.3% | 0.310 | Q3 | 44.6% |
| 2024 | 1.0 | Q4 | 15.5% | 0.348 | Q3 | 50.4% |
| 2023 | 1.0 | Q4 | 15.8% | 0.328 | Q3 | 51.6% |
| 2022 | 0.9 | 14.5% | 0.246 | Q4 | 44.4% | |
| 2021 | — | 34.6% | 0.280 | Q4 | 49.2% | |
| 2020 | — | — | 0.358 | Q4 | 56.0% | |
| 2019 | — | — | 0.356 | Q3 | 57.6% | |
| 2018 | — | — | 0.301 | Q3 | 50.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2090-2433
ISSN
1110-1164
country
EGcoverage
2011-2026